Skip to content

Author

Shoma Nishibori

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Pharmacokinetics and safety of an engineered anti-feline PD-1 chimeric antibody following repeated intravenous and subcutaneous administration in healthy cats.

Immune checkpoint inhibitors targeting programmed cell death-1 (PD-1) represent a promising strategy in feline oncology. We previously developed an anti-feline PD-1 monoclonal antibody and engineered an effector-silent variant, 1A1-2-fIgG1-M2, to abolish cytotoxic functions. However, the safety profile and plasma pharm...

Shoma Nishibori, Toshinori Shiga, T. Tsukui et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.